InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Browse the complete record of transactions filed by Eaton Bruce, Vice-Président Exécutif, Responsable Commercial. Director active across 1 companies, notably Editas Medicine, Inc.. Aggregated, 12 disclosures have been recorded. Total volume traded: €65k. The latest transaction was disclosed on 3 June 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations12 total
€12,0511,123 shares@ €10.73090.0060% mcap18.4% of flow
Common Stock
SEC:0001415889-22-006162:0·
€3,686297 shares@ €12.41060.0018% mcap5.6% of flow
Common Stock
SEC:0001415889-22-004837:0·
€13,978287 shares@ €48.70310.0070% mcap21.4% of flow
Common Stock
SEC:0001415889-22-003709:0·
€6,284403 shares@ €15.59320.0031% mcap9.6% of flow
Common Stock
SEC:0001415889-22-002656:0·
037,593 shares0
Common Stock
SEC:0001415889-22-001225·
037,593 shares0
Common Stock
SEC:0001415889-22-001225:0·
€4,652302 shares@ €15.40340.0023% mcap31.6% of flow
Common Stock
SEC:0001415889-22-001195·
€4,652302 shares@ €15.40340.0023% mcap7.1% of flow
Common Stock
SEC:0001415889-22-001195:0·
03,472 shares0
Common Stock
SEC:0001179110-21-011227·
03,472 shares0
Common Stock
SEC:0001179110-21-011227:0·
€10,055287 shares@ €35.03420.0050% mcap68.4% of flow
Common Stock
SEC:0001179110-21-010059·
€10,055287 shares@ €35.03420.0050% mcap15.4% of flow
Common Stock
SEC:0001179110-21-010059:0·
12 of 12 declarations
About Eaton Bruce
Bruce Eaton is the Executive Vice President and Chief Business Officer at Editas Medicine, Inc. In this role, he oversees business operations and strategy for the company. Bruce is committed to promoting growth and innovation, thereby contributing to Editas's position in the biotechnology market.
